Cardiovascular Risk Reduction
Cardiovascular risk reduction is the coordinated management of factors that contribute to atherosclerotic heart attack, stroke and peripheral artery disease.
Key points
- Risk is cumulative: modest abnormalities in several factors may matter more than one isolated result.
- Targets and medicine thresholds differ between primary prevention and people with established vascular disease.
- A useful plan prioritises the changes with the greatest likely benefit and checks whether they are sustainable.
The listings below are not a universal prevention bundle; absolute risk, bleeding risk, organ function and treatment preferences matter.
Turning measurements into priorities
Assessment combines repeated blood pressure, lipid profile, diabetes status, smoking, age, family history and kidney or inflammatory disease. Lifestyle discussion should be specific: smoking support, movement, dietary pattern, sleep and weight goals are selected according to the person’s main risks rather than generic perfection.
Medicine decisions
Statins, antihypertensives and glucose-lowering medicines reduce different components of risk and require their own monitoring. Antiplatelet treatment can prevent recurrent arterial events but adds bleeding risk and is not routinely indicated solely because a risk score is elevated. Adherence and adverse effects should be reviewed openly.
When to seek urgent care
Call emergency services for chest pressure, sudden facial droop, arm weakness or speech difficulty, fainting, marked breathlessness or a suddenly painful cold limb.